Florida’s largest marijuana provider is making history on Wall Street. Trulieve Cannabis Co. has received approval to list on the New York Stock Exchange, becoming the first U.S. cannabis company to trade on a major American exchange. Trading under the ticker symbol TRLV begins Wednesday morning, coinciding with the closure of the company’s long-standing listing on the Canadian Stock Exchange, where it had traded since 2018.
A Milestone for the Cannabis Industry
The NYSE listing marks a significant shift in how the U.S. financial establishment views the cannabis sector. Trulieve CEO and founder Kim Rivers called the move an opportunity to broaden the company’s reach, saying the listing would “expand our shareholder base, increase liquidity, and raise awareness for the benefits of medical marijuana.”
The timing follows a regulatory development at the federal level. Acting Attorney General Todd Blanche reclassified marijuana to Schedule III in April, a designation that acknowledges recognized medical use and indicates moderate to low potential for dependence. That change eased some of the regulatory uncertainty that had long kept cannabis companies from accessing major U.S. exchanges.
Recreational Push Falls Short in Florida
Trulieve has not limited its ambitions to the medical market. The company bankrolled the Smart & Safe Florida advocacy group, which placed a recreational cannabis measure on Florida’s 2024 ballot. The initiative drew nearly 56% support from voters — a strong showing, but short of the 60% threshold required for constitutional amendments to pass in Florida.
A subsequent ballot effort, also backed by Trulieve, ran into legal trouble. Florida Secretary of State Cord Byrd issued a directive invalidating more than 70,000 petition signatures, effectively derailing the campaign’s path to the ballot. The Florida Supreme Court declined to revisit Smart & Safe’s legal challenge against that directive in March, closing off that avenue of relief. Florida’s regulatory landscape is shifting in other ways as well — for more on state-level initiatives affecting residents, see Florida Lt. Governor Jay Collins’s upcoming Senior Protection Initiative.
What’s Next
With the Canadian delisting finalized Tuesday, Trulieve’s full focus turns to its U.S. exchange debut. The NYSE listing could attract a broader pool of institutional investors who were previously unable or unwilling to hold shares in a company traded only on foreign exchanges.
The move also arrives as Florida’s broader business and entrepreneurial climate draws attention. Florida veterans recently completed an FSU entrepreneurship program, reflecting growing interest in the state as a hub for emerging industries.
For the cannabis sector broadly, Trulieve’s NYSE debut will be closely watched as a test of whether the Schedule III reclassification and shifting political winds have meaningfully lowered the barriers separating cannabis companies from mainstream American capital markets.